tiprankstipranks
PharmaCom BioVet Inc (PHMB)
OTHER OTC:PHMB
US Market

PharmaCom BioVet (PHMB) Price & Analysis

14 Followers

PHMB Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

PHMB FAQ

What was PharmaCom BioVet Inc’s price range in the past 12 months?
Currently, no data Available
What is PharmaCom BioVet Inc’s market cap?
PharmaCom BioVet Inc’s market cap is $10.79K.
    When is PharmaCom BioVet Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were PharmaCom BioVet Inc’s earnings last quarter?
    Currently, no data Available
    Is PharmaCom BioVet Inc overvalued?
    According to Wall Street analysts PharmaCom BioVet Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does PharmaCom BioVet Inc pay dividends?
      PharmaCom BioVet Inc does not currently pay dividends.
      What is PharmaCom BioVet Inc’s EPS estimate?
      PharmaCom BioVet Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does PharmaCom BioVet Inc have?
      PharmaCom BioVet Inc has 10,784,783,000 shares outstanding.
        What happened to PharmaCom BioVet Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of PharmaCom BioVet Inc?
        Currently, no hedge funds are holding shares in PHMB
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          PharmaCom BioVet Inc

          PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
          Similar Stocks
          Company
          Price & Change
          Follow
          Jaguar Animal Health
          MSP Recovery
          Universe Pharmaceuticals
          NewGenIvf Group
          Virax Biolabs Group Ltd. Class A
          Popular Stocks